Using a novel live chimeric virus vaccine candidate, BinJ/DENV2-prME, we explored a panel of pharmaceutical excipients to mitigate vaccine loss during the drying and storage process

jamha April 2, 2023 0 Comments

Using a novel live chimeric virus vaccine candidate, BinJ/DENV2-prME, we explored a panel of pharmaceutical excipients to mitigate vaccine loss during the drying and storage process. explored a panel of pharmaceutical excipients to mitigate vaccine loss during the drying and storage process. This screening identified human serum albumin (HSA) as the lead stabilizing excipient. When […]

Read MoreRead More

(A) Control clones expressing P35 present no modifications in E-cad or integrin (PS1)

jamha February 8, 2022 0 Comments

(A) Control clones expressing P35 present no modifications in E-cad or integrin (PS1). 75h post induction at 25C. Sibling Itraconazole (Sporanox) clone sizes are likened in the wing pouch and symbolized as the percent of wing pouch region for over 100 clones, using the control FRT42D clones induced, assessed and cultured in parallel. (I) The […]

Read MoreRead More

Biochim Biophys Acta Mol Cell Res

jamha January 15, 2022 0 Comments

Biochim Biophys Acta Mol Cell Res. 1.?Intro Mammalian pores and skin comprises the outer and inner epidermis, separated with a basement membrane. 1 Your skin is an all natural physical and immune system protective hurdle that prevents not merely the penetration of dangerous 5-HT4 antagonist 1 microorganisms, but dehydration also. 2 , 3 After the […]

Read MoreRead More